Skip to content

Dr. Gülsen Mutluoglu

Active
Private limited companyfounded 20233 yrs activeKaasstraat 38, 3404 Landen, BelgiumKBO/BCE: BE 0805.221.744

Dr. Gülsen Mutluoglu has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €97k and a net result of €44k. Its solvency ranks better than 68% of 16426 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
96 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100▲+29
Growth52
Track record94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €9k at 30 days acceptable
Liquidity ample (current ratio 4.98 against 1.86 in 2024; short-term debt: 20.1% and cash: 41.7% of total assets), and 21% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 3 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
79%
Return on assets
36%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 27-04-2026, 3 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
3 d early
2024
16 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
18-09-2026 today30-09-2026 close30-04-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€97k▲ 83.5%
2024 · €53k
2024: €53k
2024 → 2025
Total assets
€123k▲ 7.4%
2024 · €115k
2024: €115k
2024 → 2025
Net result
€44k▼ 14.9%
2024 · €52k
2024: €52k
2024 → 2025
Working capital
€98k▲ 85.6%
2024 · €53k
2024: €53k
2024 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20242025Trend
Equity€53k-€97k▲ 83.5%
Operating result€68k-€60k▼ 11.3%
Net result€52k-€44k▼ 14.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20k€40k€60kOperating result 2024: €68k€68kNet result 2024: €52k€52kOperating result 2025: €60k€60kNet result 2025: €44k€44k20242025
The operating result falls in 2025; 2025 is 11% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €123k
Equity €97k▲ 83.5%
Debt €26k▼ 58.1%
The debt ratio falls from 53.8% to 21.0%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
Solvency
79.0%
2024 · 46.2%
Current ratio
4.98
2024 · 1.86
Quick ratio
4.98
2024 · 1.86
Debt / equity
0.27
2024 · 1.16
ROE
45.5%
2024 · 98.1%
ROA
36.0%
2024 · 45.4%
Debt
€26k
2024 · €62k
Debt ≤ 1 year
€25k
2024 · €62k
Income taxes
€13k
2024 · €15k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€115k€123k
Current assets29/58€115k€123k
Cash at bank and in hand54/58€33k€51k
Deferred charges and accrued income490/1€82k€72k
Equity and liabilities
Total equity and liabilities10/49€115k€123k
Equity10/15€53k€97k
Contributions10/11€1k€1k=
Reserves13€52k€96k
Distributable reserves133€52k€96k
Amounts payable17/49€62k€26k
Amounts payable within one year42/48€62k€25k
Trade debts44€4k€4k
Suppliers440/4€4k€4k
Taxes, remuneration and social security45€17k€16k
Taxes450/3€15k€13k
Remuneration and social security454/9€3k€3k=
Other amounts payable47/48€40k€5k
Accrued charges and deferred income492/3-€1k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k-
Gross operating margin9900€69k€60k
Operating profit (loss)9901€68k€60k
Financial income75/76B€3-
Recurring financial income75€3-
Financial charges65/66B€1k€3k
Recurring financial charges65€1k€3k
Profit (loss) for the period before taxes9903€67k€57k
Income taxes67/77€15k€13k
Profit (loss) for the period9904€52k€44k
Profit (loss) for the period to be appropriated9905€52k€44k
Appropriation of the result
Profit (loss) to be appropriated9906€52k€44k
Transfer to equity691/2€52k€44k
To other reserves6921€52k€44k

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 30-04-2027
2026
27-04
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
Financial Liquidity triplescurrent ratio 4.98
Current ratio from 1.86 to 4.98; short-term debt falls from €62k to €25k.
14-04
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Landen · 1 establishment unit since 2023
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Kaasstraat 383404 Landen
Ground area
1,001 m²
Building footprint
117 m²
Volume, LiDAR
556 m³
Parcel 24003B0213/00R000, Flanders · tallest building 7.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Gülsen Mutluoglu
Kaasstraat 38, 3404 LandenSpecialist medical practice
since 20232.351.861.010
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24003B0213/00R000 Flanders 1,001 m² 1 · 117 m² 7.8 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 699 companies in sector 86910 we hold annual accounts for 521. 336 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded29-08-2023
Fiscal year end30-09
Activities, NACEBEL
86901Human health activities
86910Medical imaging and medical laboratories
74909Other professional, scientific and technical activities
74999Other professional, scientific and technical activities
85599Other education
85699Other educational support services
Sources
Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers

Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.